

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of light stimulus involved in visual perception (GO:0050908) | 8.60231633 |
| 2 | detection of light stimulus involved in sensory perception (GO:0050962) | 8.60231633 |
| 3 | phototransduction (GO:0007602) | 8.11101476 |
| 4 | GMP metabolic process (GO:0046037) | 7.91039517 |
| 5 | detection of light stimulus (GO:0009583) | 7.82977923 |
| 6 | phototransduction, visible light (GO:0007603) | 7.78680507 |
| 7 | detection of visible light (GO:0009584) | 7.62328503 |
| 8 | visual perception (GO:0007601) | 7.31995012 |
| 9 | sensory perception of light stimulus (GO:0050953) | 7.22992537 |
| 10 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.27908685 |
| 11 | eye photoreceptor cell differentiation (GO:0001754) | 6.23045542 |
| 12 | photoreceptor cell differentiation (GO:0046530) | 6.23045542 |
| 13 | retina development in camera-type eye (GO:0060041) | 5.98901010 |
| 14 | cellular response to light stimulus (GO:0071482) | 5.89537090 |
| 15 | protein-chromophore linkage (GO:0018298) | 5.83649405 |
| 16 | regulation of guanylate cyclase activity (GO:0031282) | 5.61569059 |
| 17 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.60341212 |
| 18 | detection of external stimulus (GO:0009581) | 5.51246570 |
| 19 | detection of abiotic stimulus (GO:0009582) | 5.41158429 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.40707758 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.23654626 |
| 22 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.19717080 |
| 23 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.73691781 |
| 24 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.65391106 |
| 25 | nonmotile primary cilium assembly (GO:0035058) | 4.50294093 |
| 26 | synaptic vesicle maturation (GO:0016188) | 4.48518410 |
| 27 | protein localization to synapse (GO:0035418) | 4.39264110 |
| 28 | regulation of cGMP metabolic process (GO:0030823) | 4.33396290 |
| 29 | sodium ion export (GO:0071436) | 4.29738751 |
| 30 | cellular potassium ion homeostasis (GO:0030007) | 4.24171150 |
| 31 | dendritic spine morphogenesis (GO:0060997) | 4.20893466 |
| 32 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 4.05664117 |
| 33 | response to pheromone (GO:0019236) | 4.04673739 |
| 34 | neuronal action potential propagation (GO:0019227) | 3.95192957 |
| 35 | membrane depolarization during action potential (GO:0086010) | 3.94651652 |
| 36 | postsynaptic membrane organization (GO:0001941) | 3.88332877 |
| 37 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.87793432 |
| 38 | behavioral response to nicotine (GO:0035095) | 3.82796168 |
| 39 | cellular response to radiation (GO:0071478) | 3.82642856 |
| 40 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.75726991 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.72147537 |
| 42 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.70464949 |
| 43 | retina layer formation (GO:0010842) | 3.70191119 |
| 44 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.69279751 |
| 45 | post-embryonic morphogenesis (GO:0009886) | 3.63896513 |
| 46 | regulation of cGMP biosynthetic process (GO:0030826) | 3.60592286 |
| 47 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.60199222 |
| 48 | sensory perception (GO:0007600) | 3.56967664 |
| 49 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.54602126 |
| 50 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.48943024 |
| 51 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.46247765 |
| 52 | synaptic vesicle exocytosis (GO:0016079) | 3.42231194 |
| 53 | neuron development (GO:0048666) | 3.39679364 |
| 54 | positive regulation of cGMP metabolic process (GO:0030825) | 3.39462261 |
| 55 | neuromuscular synaptic transmission (GO:0007274) | 3.36478211 |
| 56 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.36045154 |
| 57 | membrane hyperpolarization (GO:0060081) | 3.33207119 |
| 58 | transmission of nerve impulse (GO:0019226) | 3.32370532 |
| 59 | urinary tract smooth muscle contraction (GO:0014848) | 3.31692241 |
| 60 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.30044111 |
| 61 | potassium ion homeostasis (GO:0055075) | 3.25072700 |
| 62 | proline transport (GO:0015824) | 3.24910026 |
| 63 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 3.24033221 |
| 64 | synaptic transmission, glutamatergic (GO:0035249) | 3.23681377 |
| 65 | response to light stimulus (GO:0009416) | 3.21277635 |
| 66 | estrogen biosynthetic process (GO:0006703) | 3.20389368 |
| 67 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.18423322 |
| 68 | activated T cell proliferation (GO:0050798) | 3.18093832 |
| 69 | axon ensheathment in central nervous system (GO:0032291) | 3.16871966 |
| 70 | central nervous system myelination (GO:0022010) | 3.16871966 |
| 71 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.14799863 |
| 72 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.13382582 |
| 73 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.11969955 |
| 74 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.11793771 |
| 75 | regulation of synapse structural plasticity (GO:0051823) | 3.09617982 |
| 76 | membrane depolarization (GO:0051899) | 3.08909101 |
| 77 | cAMP catabolic process (GO:0006198) | 3.08165914 |
| 78 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.05040005 |
| 79 | adaptation of signaling pathway (GO:0023058) | 3.04977519 |
| 80 | neurotransmitter transport (GO:0006836) | 3.03676765 |
| 81 | response to histamine (GO:0034776) | 3.01653894 |
| 82 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.00911779 |
| 83 | cyclic nucleotide catabolic process (GO:0009214) | 3.00687563 |
| 84 | regulation of synaptic vesicle transport (GO:1902803) | 3.00486503 |
| 85 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.00459842 |
| 86 | behavioral response to ethanol (GO:0048149) | 3.00426544 |
| 87 | L-amino acid import (GO:0043092) | 3.00402063 |
| 88 | glutamate receptor signaling pathway (GO:0007215) | 2.99755857 |
| 89 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.97973760 |
| 90 | potassium ion import (GO:0010107) | 2.96706910 |
| 91 | presynaptic membrane assembly (GO:0097105) | 2.96370360 |
| 92 | chemosensory behavior (GO:0007635) | 2.94691746 |
| 93 | auditory behavior (GO:0031223) | 2.93891422 |
| 94 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.92594330 |
| 95 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.92051420 |
| 96 | mitochondrion transport along microtubule (GO:0047497) | 2.92051420 |
| 97 | glutamate secretion (GO:0014047) | 2.91192165 |
| 98 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.90895612 |
| 99 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.90560317 |
| 100 | regulation of postsynaptic membrane potential (GO:0060078) | 2.90428763 |
| 101 | presynaptic membrane organization (GO:0097090) | 2.89663003 |
| 102 | neurotransmitter secretion (GO:0007269) | 2.88136011 |
| 103 | regulation of neurotransmitter levels (GO:0001505) | 2.87292525 |
| 104 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.87129266 |
| 105 | positive regulation of synapse maturation (GO:0090129) | 2.84648028 |
| 106 | neuron-neuron synaptic transmission (GO:0007270) | 2.84558647 |
| 107 | neuromuscular process controlling posture (GO:0050884) | 2.84453198 |
| 108 | positive regulation of neurotransmitter transport (GO:0051590) | 2.84253902 |
| 109 | neuronal ion channel clustering (GO:0045161) | 2.83835151 |
| 110 | regulation of synapse maturation (GO:0090128) | 2.83038593 |
| 111 | synaptic vesicle endocytosis (GO:0048488) | 2.82854581 |
| 112 | cell communication by electrical coupling (GO:0010644) | 2.82231883 |
| 113 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.81971685 |
| 114 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.81971685 |
| 115 | righting reflex (GO:0060013) | 2.79786764 |
| 116 | startle response (GO:0001964) | 2.79502568 |
| 117 | neuron cell-cell adhesion (GO:0007158) | 2.78698894 |
| 118 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.78261710 |
| 119 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.77178405 |
| 120 | neuronal action potential (GO:0019228) | 2.74593215 |
| 121 | protein K11-linked deubiquitination (GO:0035871) | 2.71634073 |
| 122 | regulation of neurotransmitter secretion (GO:0046928) | 2.71497454 |
| 123 | cell differentiation in hindbrain (GO:0021533) | 2.71276870 |
| 124 | exploration behavior (GO:0035640) | 2.68452257 |
| 125 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.68201323 |
| 126 | axoneme assembly (GO:0035082) | 2.65516706 |
| 127 | positive regulation of membrane potential (GO:0045838) | 2.63789113 |
| 128 | mechanosensory behavior (GO:0007638) | 2.62221696 |
| 129 | adult walking behavior (GO:0007628) | 2.62112899 |
| 130 | synaptic transmission (GO:0007268) | 2.60568801 |
| 131 | regulation of neurotransmitter transport (GO:0051588) | 2.59775777 |
| 132 | L-fucose catabolic process (GO:0042355) | 2.58475637 |
| 133 | fucose catabolic process (GO:0019317) | 2.58475637 |
| 134 | L-fucose metabolic process (GO:0042354) | 2.58475637 |
| 135 | protein prenylation (GO:0018342) | 2.56443654 |
| 136 | prenylation (GO:0097354) | 2.56443654 |
| 137 | innervation (GO:0060384) | 2.55228890 |
| 138 | establishment of mitochondrion localization (GO:0051654) | 2.55122445 |
| 139 | locomotory exploration behavior (GO:0035641) | 2.54888977 |
| 140 | vocalization behavior (GO:0071625) | 2.53938250 |
| 141 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.52986774 |
| 142 | regulation of respiratory system process (GO:0044065) | 2.52908026 |
| 143 | striatum development (GO:0021756) | 2.50201542 |
| 144 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.49704577 |
| 145 | cell migration in hindbrain (GO:0021535) | 2.49495695 |
| 146 | alanine transport (GO:0032328) | 2.49247401 |
| 147 | neurotransmitter catabolic process (GO:0042135) | 2.48220973 |
| 148 | synapse assembly (GO:0007416) | 2.46642010 |
| 149 | regulation of ARF protein signal transduction (GO:0032012) | 2.46400835 |
| 150 | nucleobase catabolic process (GO:0046113) | 2.46335312 |
| 151 | primary amino compound metabolic process (GO:1901160) | 2.46229747 |
| 152 | retina homeostasis (GO:0001895) | 2.45912762 |
| 153 | cellular sodium ion homeostasis (GO:0006883) | 2.44838853 |
| 154 | short-term memory (GO:0007614) | 2.44559239 |
| 155 | regulation of respiratory gaseous exchange (GO:0043576) | 2.44354918 |
| 156 | potassium ion transmembrane transport (GO:0071805) | 2.44299259 |
| 157 | cellular potassium ion transport (GO:0071804) | 2.44299259 |
| 158 | regulation of vesicle fusion (GO:0031338) | 2.43900034 |
| 159 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.43767844 |
| 160 | positive regulation of vesicle fusion (GO:0031340) | 2.42664850 |
| 161 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.41931753 |
| 162 | serotonin metabolic process (GO:0042428) | 2.41709265 |
| 163 | neurotransmitter uptake (GO:0001504) | 2.41267041 |
| 164 | amino acid import (GO:0043090) | 2.39027501 |
| 165 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.38423024 |
| 166 | establishment of protein localization to Golgi (GO:0072600) | 2.36064069 |
| 167 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.35523932 |
| 168 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 13.3036307 |
| 169 | rhodopsin mediated signaling pathway (GO:0016056) | 12.9811248 |
| 170 | retinal cone cell development (GO:0046549) | 10.8585577 |
| 171 | photoreceptor cell maintenance (GO:0045494) | 10.6695310 |
| 172 | photoreceptor cell development (GO:0042461) | 10.4841212 |
| 173 | retinal rod cell development (GO:0046548) | 10.0531147 |
| 174 | eye photoreceptor cell development (GO:0042462) | 10.0003082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 3.29005835 |
| 2 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 3.15219284 |
| 3 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.81028524 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.69556173 |
| 5 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.68567710 |
| 6 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.56446561 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.55413137 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.52441117 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.37388410 |
| 10 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.29429520 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.12190128 |
| 12 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.01725507 |
| 13 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.01725507 |
| 14 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.01725507 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.98162599 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.97080000 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82430184 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.82016611 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.80661247 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.79266493 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.77345193 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.74573137 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.74573137 |
| 24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.73532297 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.71764162 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.69832985 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.69455222 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67416557 |
| 29 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.66044264 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64967110 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64689985 |
| 32 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.63916072 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.63286139 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.58728831 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.57741776 |
| 36 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.56500182 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.56283250 |
| 38 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53668943 |
| 39 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.51555471 |
| 40 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.51392580 |
| 41 | AR_19668381_ChIP-Seq_PC3_Human | 1.50964575 |
| 42 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.50304298 |
| 43 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.50036047 |
| 44 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.48667039 |
| 45 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.47911303 |
| 46 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.45531592 |
| 47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43076793 |
| 48 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.41253869 |
| 49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40394072 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37666791 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32713423 |
| 52 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.31501895 |
| 53 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.30722638 |
| 54 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.27903505 |
| 55 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27518237 |
| 56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27418375 |
| 57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26598366 |
| 58 | TCF4_23295773_ChIP-Seq_U87_Human | 1.26427624 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24646065 |
| 60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23391684 |
| 61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20202914 |
| 62 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19268680 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19044056 |
| 64 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.18865117 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17295701 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16368098 |
| 67 | TBL1_22424771_ChIP-Seq_293T_Human | 1.16329021 |
| 68 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.15484472 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15210446 |
| 70 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15056914 |
| 71 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13534542 |
| 72 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.13383349 |
| 73 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.13030855 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 1.12937855 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12859622 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12384014 |
| 77 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12180725 |
| 78 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.10904024 |
| 79 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09909588 |
| 80 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09502229 |
| 81 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.09359715 |
| 82 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09000762 |
| 83 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09000762 |
| 84 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08878401 |
| 85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08792536 |
| 86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08588194 |
| 87 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.08411913 |
| 88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07918057 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07629559 |
| 90 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.07394014 |
| 91 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06756730 |
| 92 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05613372 |
| 93 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.05498540 |
| 94 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05241173 |
| 95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05110675 |
| 96 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04308846 |
| 97 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.04128598 |
| 98 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 1.03786335 |
| 99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03440354 |
| 100 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.02634124 |
| 101 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02515236 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01627023 |
| 103 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01329275 |
| 104 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.01219974 |
| 105 | P300_19829295_ChIP-Seq_ESCs_Human | 1.00733084 |
| 106 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00469652 |
| 107 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00468745 |
| 108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99459650 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99181978 |
| 110 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99008181 |
| 111 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.98374885 |
| 112 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98252281 |
| 113 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97796732 |
| 114 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97796732 |
| 115 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96810140 |
| 116 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96668787 |
| 117 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96418611 |
| 118 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96034968 |
| 119 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95773775 |
| 120 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.95366087 |
| 121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95303691 |
| 122 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.95170263 |
| 123 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95142031 |
| 124 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95100642 |
| 125 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95011642 |
| 126 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.94912296 |
| 127 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93641171 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93546135 |
| 129 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93288470 |
| 130 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93068919 |
| 131 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92636271 |
| 132 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.92286744 |
| 133 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92222118 |
| 134 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.92180292 |
| 135 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92043766 |
| 136 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.91277687 |
| 137 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.90305947 |
| 138 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90007102 |
| 139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88903645 |
| 140 | ERA_21632823_ChIP-Seq_H3396_Human | 0.88361678 |
| 141 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.88204076 |
| 142 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88027685 |
| 143 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.87661987 |
| 144 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86842557 |
| 145 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85244331 |
| 146 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84648552 |
| 147 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84345265 |
| 148 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.82593979 |
| 149 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.82196673 |
| 150 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.82105706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 8.62357146 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 8.44668825 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.78069947 |
| 4 | MP0005253_abnormal_eye_physiology | 6.09700847 |
| 5 | MP0005195_abnormal_posterior_eye | 3.55200118 |
| 6 | MP0003950_abnormal_plasma_membrane | 3.43381937 |
| 7 | MP0005391_vision/eye_phenotype | 3.03062498 |
| 8 | MP0001324_abnormal_eye_pigmentation | 2.87091422 |
| 9 | MP0002653_abnormal_ependyma_morphology | 2.66804875 |
| 10 | MP0002229_neurodegeneration | 2.56467495 |
| 11 | MP0002638_abnormal_pupillary_reflex | 2.54967037 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.47747020 |
| 13 | MP0002090_abnormal_vision | 2.39456708 |
| 14 | MP0004233_abnormal_muscle_weight | 2.06891236 |
| 15 | MP0002752_abnormal_somatic_nervous | 2.04920852 |
| 16 | MP0000569_abnormal_digit_pigmentation | 1.93621962 |
| 17 | MP0008877_abnormal_DNA_methylation | 1.86799659 |
| 18 | MP0002735_abnormal_chemical_nociception | 1.81237757 |
| 19 | MP0005394_taste/olfaction_phenotype | 1.74843938 |
| 20 | MP0005499_abnormal_olfactory_system | 1.74843938 |
| 21 | MP0001502_abnormal_circadian_rhythm | 1.71305934 |
| 22 | MP0004130_abnormal_muscle_cell | 1.71015472 |
| 23 | MP0006292_abnormal_olfactory_placode | 1.70448061 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.68002158 |
| 25 | MP0003879_abnormal_hair_cell | 1.65890695 |
| 26 | MP0006276_abnormal_autonomic_nervous | 1.65406465 |
| 27 | MP0002882_abnormal_neuron_morphology | 1.61604614 |
| 28 | MP0004859_abnormal_synaptic_plasticity | 1.59742998 |
| 29 | MP0003880_abnormal_central_pattern | 1.58044485 |
| 30 | MP0002736_abnormal_nociception_after | 1.53303717 |
| 31 | MP0009046_muscle_twitch | 1.53025359 |
| 32 | MP0004885_abnormal_endolymph | 1.51619183 |
| 33 | MP0003646_muscle_fatigue | 1.50008872 |
| 34 | MP0008789_abnormal_olfactory_epithelium | 1.42598969 |
| 35 | MP0003195_calcinosis | 1.39106405 |
| 36 | MP0001486_abnormal_startle_reflex | 1.38691209 |
| 37 | MP0004043_abnormal_pH_regulation | 1.38518759 |
| 38 | MP0003635_abnormal_synaptic_transmissio | 1.36886232 |
| 39 | MP0003329_amyloid_beta_deposits | 1.32525392 |
| 40 | MP0001984_abnormal_olfaction | 1.31888745 |
| 41 | MP0002064_seizures | 1.29967021 |
| 42 | MP0004270_analgesia | 1.24399056 |
| 43 | MP0003690_abnormal_glial_cell | 1.23736853 |
| 44 | MP0000015_abnormal_ear_pigmentation | 1.19912722 |
| 45 | MP0001764_abnormal_homeostasis | 1.19285701 |
| 46 | MP0005171_absent_coat_pigmentation | 1.18512961 |
| 47 | MP0002272_abnormal_nervous_system | 1.18037028 |
| 48 | MP0010030_abnormal_orbit_morphology | 1.17875522 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.16213733 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.11929201 |
| 51 | MP0004381_abnormal_hair_follicle | 1.11190714 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.08808788 |
| 53 | MP0000372_irregular_coat_pigmentation | 1.06527031 |
| 54 | MP0000920_abnormal_myelination | 1.05355934 |
| 55 | MP0009745_abnormal_behavioral_response | 1.05129255 |
| 56 | MP0003890_abnormal_embryonic-extraembry | 1.02895565 |
| 57 | MP0002734_abnormal_mechanical_nocicepti | 1.02888092 |
| 58 | MP0004142_abnormal_muscle_tone | 1.00935432 |
| 59 | MP0002127_abnormal_cardiovascular_syste | 1.00698668 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 0.98435088 |
| 61 | MP0003123_paternal_imprinting | 0.97455584 |
| 62 | MP0002067_abnormal_sensory_capabilities | 0.95892076 |
| 63 | MP0002063_abnormal_learning/memory/cond | 0.95852509 |
| 64 | MP0003634_abnormal_glial_cell | 0.94514181 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.91257088 |
| 66 | MP0005535_abnormal_body_temperature | 0.88370460 |
| 67 | MP0003172_abnormal_lysosome_physiology | 0.85878943 |
| 68 | MP0002332_abnormal_exercise_endurance | 0.85391279 |
| 69 | MP0003136_yellow_coat_color | 0.85197192 |
| 70 | MP0002572_abnormal_emotion/affect_behav | 0.82862886 |
| 71 | MP0001188_hyperpigmentation | 0.82536601 |
| 72 | MP0002184_abnormal_innervation | 0.81220813 |
| 73 | MP0000631_abnormal_neuroendocrine_gland | 0.80772479 |
| 74 | MP0005248_abnormal_Harderian_gland | 0.80404726 |
| 75 | MP0001968_abnormal_touch/_nociception | 0.80365685 |
| 76 | MP0010386_abnormal_urinary_bladder | 0.78969599 |
| 77 | MP0002234_abnormal_pharynx_morphology | 0.78861465 |
| 78 | MP0001905_abnormal_dopamine_level | 0.78661305 |
| 79 | MP0005448_abnormal_energy_balance | 0.78116261 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.77607430 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 0.77239096 |
| 82 | MP0004019_abnormal_vitamin_homeostasis | 0.75110465 |
| 83 | MP0002095_abnormal_skin_pigmentation | 0.74485062 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.73788722 |
| 85 | MP0003283_abnormal_digestive_organ | 0.73556466 |
| 86 | MP0001286_abnormal_eye_development | 0.69786443 |
| 87 | MP0001963_abnormal_hearing_physiology | 0.69108575 |
| 88 | MP0000427_abnormal_hair_cycle | 0.67677468 |
| 89 | MP0005197_abnormal_uvea_morphology | 0.67664111 |
| 90 | MP0000955_abnormal_spinal_cord | 0.67146662 |
| 91 | MP0002697_abnormal_eye_size | 0.67001554 |
| 92 | MP0008995_early_reproductive_senescence | 0.66056758 |
| 93 | MP0005671_abnormal_response_to | 0.65582987 |
| 94 | MP0004147_increased_porphyrin_level | 0.65566852 |
| 95 | MP0002152_abnormal_brain_morphology | 0.65539284 |
| 96 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65357833 |
| 97 | MP0005623_abnormal_meninges_morphology | 0.64652148 |
| 98 | MP0003045_fibrosis | 0.64258324 |
| 99 | MP0000778_abnormal_nervous_system | 0.64172589 |
| 100 | MP0003724_increased_susceptibility_to | 0.61657539 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.61294656 |
| 102 | MP0004924_abnormal_behavior | 0.61294656 |
| 103 | MP0004811_abnormal_neuron_physiology | 0.61129148 |
| 104 | MP0000604_amyloidosis | 0.60810773 |
| 105 | MP0005187_abnormal_penis_morphology | 0.60024198 |
| 106 | MP0002066_abnormal_motor_capabilities/c | 0.59707134 |
| 107 | MP0003632_abnormal_nervous_system | 0.59328928 |
| 108 | MP0008569_lethality_at_weaning | 0.58526992 |
| 109 | MP0001501_abnormal_sleep_pattern | 0.56173930 |
| 110 | MP0002557_abnormal_social/conspecific_i | 0.55884770 |
| 111 | MP0005670_abnormal_white_adipose | 0.54182274 |
| 112 | MP0003122_maternal_imprinting | 0.53643099 |
| 113 | MP0003861_abnormal_nervous_system | 0.49545111 |
| 114 | MP0001970_abnormal_pain_threshold | 0.48706075 |
| 115 | MP0003787_abnormal_imprinting | 0.48070781 |
| 116 | MP0003633_abnormal_nervous_system | 0.47945458 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.47576846 |
| 118 | MP0000751_myopathy | 0.45567786 |
| 119 | MP0000026_abnormal_inner_ear | 0.43863975 |
| 120 | MP0001293_anophthalmia | 0.43379485 |
| 121 | MP0003631_nervous_system_phenotype | 0.43017068 |
| 122 | MP0005076_abnormal_cell_differentiation | 0.42713386 |
| 123 | MP0001440_abnormal_grooming_behavior | 0.42658461 |
| 124 | MP0004215_abnormal_myocardial_fiber | 0.42110023 |
| 125 | MP0003121_genomic_imprinting | 0.40129342 |
| 126 | MP0004133_heterotaxia | 0.38849672 |
| 127 | MP0002102_abnormal_ear_morphology | 0.37874645 |
| 128 | MP0005646_abnormal_pituitary_gland | 0.37046715 |
| 129 | MP0004742_abnormal_vestibular_system | 0.35768976 |
| 130 | MP0003137_abnormal_impulse_conducting | 0.34785909 |
| 131 | MP0008961_abnormal_basal_metabolism | 0.34634109 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.33057436 |
| 133 | MP0009780_abnormal_chondrocyte_physiolo | 0.32543462 |
| 134 | MP0004085_abnormal_heartbeat | 0.31184191 |
| 135 | MP0008872_abnormal_physiological_respon | 0.30594319 |
| 136 | MP0002069_abnormal_eating/drinking_beha | 0.29690020 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.29539505 |
| 138 | MP0002082_postnatal_lethality | 0.29463560 |
| 139 | MP0010770_preweaning_lethality | 0.29463560 |
| 140 | MP0010769_abnormal_survival | 0.29089416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 9.91100933 |
| 2 | Abnormal rod and cone electroretinograms (HP:0008323) | 9.72640081 |
| 3 | Chorioretinal atrophy (HP:0000533) | 8.75485941 |
| 4 | Central scotoma (HP:0000603) | 8.15837445 |
| 5 | Pigmentary retinal degeneration (HP:0001146) | 7.99874654 |
| 6 | Pendular nystagmus (HP:0012043) | 7.89239361 |
| 7 | Scotoma (HP:0000575) | 7.11056025 |
| 8 | Abolished electroretinogram (ERG) (HP:0000550) | 6.95511374 |
| 9 | Attenuation of retinal blood vessels (HP:0007843) | 6.74295051 |
| 10 | Abnormality of macular pigmentation (HP:0008002) | 6.65899733 |
| 11 | Dyschromatopsia (HP:0007641) | 6.44259679 |
| 12 | Decreased central vision (HP:0007663) | 5.84025784 |
| 13 | Posterior subcapsular cataract (HP:0007787) | 5.77145634 |
| 14 | Type II diabetes mellitus (HP:0005978) | 5.36222688 |
| 15 | Severe visual impairment (HP:0001141) | 5.23100342 |
| 16 | Photophobia (HP:0000613) | 5.00321570 |
| 17 | Vitreoretinal degeneration (HP:0000655) | 4.75230861 |
| 18 | Increased corneal curvature (HP:0100692) | 4.68549976 |
| 19 | Keratoconus (HP:0000563) | 4.68549976 |
| 20 | Focal motor seizures (HP:0011153) | 4.68404562 |
| 21 | Macular degeneration (HP:0000608) | 4.66212923 |
| 22 | Cone-rod dystrophy (HP:0000548) | 4.55762861 |
| 23 | Hyperventilation (HP:0002883) | 4.16446300 |
| 24 | Constricted visual fields (HP:0001133) | 4.01753919 |
| 25 | Retinitis pigmentosa (HP:0000510) | 4.00266690 |
| 26 | Atonic seizures (HP:0010819) | 3.87889361 |
| 27 | Subcapsular cataract (HP:0000523) | 3.50183907 |
| 28 | Choroideremia (HP:0001139) | 3.36577542 |
| 29 | Clumsiness (HP:0002312) | 3.33133822 |
| 30 | Dialeptic seizures (HP:0011146) | 3.32129500 |
| 31 | Broad-based gait (HP:0002136) | 3.26711695 |
| 32 | Papilledema (HP:0001085) | 3.17923616 |
| 33 | Absence seizures (HP:0002121) | 3.15442129 |
| 34 | Absent speech (HP:0001344) | 3.11917567 |
| 35 | Progressive visual loss (HP:0000529) | 2.92699995 |
| 36 | Gaze-evoked nystagmus (HP:0000640) | 2.77481706 |
| 37 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.77152488 |
| 38 | Protruding tongue (HP:0010808) | 2.71312594 |
| 39 | Polyphagia (HP:0002591) | 2.70486713 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 2.68702368 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.66414675 |
| 42 | Generalized tonic-clonic seizures (HP:0002069) | 2.65371381 |
| 43 | Nephronophthisis (HP:0000090) | 2.63873245 |
| 44 | Impaired smooth pursuit (HP:0007772) | 2.58508780 |
| 45 | Status epilepticus (HP:0002133) | 2.56053791 |
| 46 | Generalized hypopigmentation of hair (HP:0011358) | 2.53249968 |
| 47 | Gait imbalance (HP:0002141) | 2.52861375 |
| 48 | Polydipsia (HP:0001959) | 2.51434568 |
| 49 | Abnormal drinking behavior (HP:0030082) | 2.51434568 |
| 50 | Epileptiform EEG discharges (HP:0011182) | 2.48126336 |
| 51 | Congenital primary aphakia (HP:0007707) | 2.45296716 |
| 52 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.44814384 |
| 53 | Inability to walk (HP:0002540) | 2.44123195 |
| 54 | Wide nasal bridge (HP:0000431) | 2.43979440 |
| 55 | Prolonged QT interval (HP:0001657) | 2.42658678 |
| 56 | Limb dystonia (HP:0002451) | 2.40133638 |
| 57 | Spastic gait (HP:0002064) | 2.38787057 |
| 58 | Drooling (HP:0002307) | 2.37704496 |
| 59 | EEG with generalized epileptiform discharges (HP:0011198) | 2.36013174 |
| 60 | Excessive salivation (HP:0003781) | 2.33530276 |
| 61 | Blue irides (HP:0000635) | 2.32745490 |
| 62 | Hypsarrhythmia (HP:0002521) | 2.30718802 |
| 63 | Fair hair (HP:0002286) | 2.28950389 |
| 64 | Abnormality of the renal medulla (HP:0100957) | 2.24800648 |
| 65 | Agitation (HP:0000713) | 2.24730667 |
| 66 | Chronic hepatic failure (HP:0100626) | 2.18937753 |
| 67 | Abnormal EKG (HP:0003115) | 2.17551078 |
| 68 | Abnormality of the corticospinal tract (HP:0002492) | 2.17465167 |
| 69 | Polyuria (HP:0000103) | 2.14125303 |
| 70 | Nephrogenic diabetes insipidus (HP:0009806) | 2.11624792 |
| 71 | Sleep apnea (HP:0010535) | 2.08268182 |
| 72 | Abnormality of the renal cortex (HP:0011035) | 2.07684457 |
| 73 | Widely spaced teeth (HP:0000687) | 2.06489769 |
| 74 | Optic disc pallor (HP:0000543) | 2.04381145 |
| 75 | Stomach cancer (HP:0012126) | 2.03617564 |
| 76 | Decreased circulating renin level (HP:0003351) | 2.02736699 |
| 77 | Progressive inability to walk (HP:0002505) | 2.02121503 |
| 78 | Congenital stationary night blindness (HP:0007642) | 12.7462230 |
| 79 | Bony spicule pigmentary retinopathy (HP:0007737) | 10.5226274 |
| 80 | Visual hallucinations (HP:0002367) | 1.98733794 |
| 81 | Medial flaring of the eyebrow (HP:0010747) | 1.98390245 |
| 82 | Dysdiadochokinesis (HP:0002075) | 1.90688010 |
| 83 | Tented upper lip vermilion (HP:0010804) | 1.90410600 |
| 84 | Poor coordination (HP:0002370) | 1.87902059 |
| 85 | Iris hypopigmentation (HP:0007730) | 1.87474806 |
| 86 | Amblyopia (HP:0000646) | 1.87415261 |
| 87 | Polar cataract (HP:0010696) | 1.87079260 |
| 88 | Intellectual disability, severe (HP:0010864) | 1.86668977 |
| 89 | Clonus (HP:0002169) | 1.84114875 |
| 90 | Progressive cerebellar ataxia (HP:0002073) | 1.83142749 |
| 91 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.80698475 |
| 92 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.80698475 |
| 93 | Ulnar claw (HP:0001178) | 1.79588624 |
| 94 | Ocular albinism (HP:0001107) | 1.79583467 |
| 95 | Akinesia (HP:0002304) | 1.79386595 |
| 96 | Fetal akinesia sequence (HP:0001989) | 1.78551198 |
| 97 | Stereotypic behavior (HP:0000733) | 1.78312602 |
| 98 | Horizontal nystagmus (HP:0000666) | 1.77498920 |
| 99 | Retinal atrophy (HP:0001105) | 1.76753780 |
| 100 | Septo-optic dysplasia (HP:0100842) | 1.75730605 |
| 101 | Spastic tetraplegia (HP:0002510) | 1.74764221 |
| 102 | Progressive microcephaly (HP:0000253) | 1.73334353 |
| 103 | Amelogenesis imperfecta (HP:0000705) | 1.70642490 |
| 104 | Slow saccadic eye movements (HP:0000514) | 1.70101848 |
| 105 | Mutism (HP:0002300) | 1.69393542 |
| 106 | Annular pancreas (HP:0001734) | 1.69036918 |
| 107 | Abnormal urine output (HP:0012590) | 1.68583969 |
| 108 | Poor eye contact (HP:0000817) | 1.68534107 |
| 109 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.68198985 |
| 110 | Vaginal atresia (HP:0000148) | 1.68056086 |
| 111 | Epileptic encephalopathy (HP:0200134) | 1.67060880 |
| 112 | Genital tract atresia (HP:0001827) | 1.66094143 |
| 113 | Tubular atrophy (HP:0000092) | 1.66041106 |
| 114 | Pancreatic fibrosis (HP:0100732) | 1.60551270 |
| 115 | Febrile seizures (HP:0002373) | 1.58241868 |
| 116 | Optic atrophy (HP:0000648) | 1.56532663 |
| 117 | Abnormality of the lower motor neuron (HP:0002366) | 1.53813407 |
| 118 | True hermaphroditism (HP:0010459) | 1.51787309 |
| 119 | Abnormality of the parathyroid morphology (HP:0011766) | 1.47628304 |
| 120 | Sclerocornea (HP:0000647) | 1.46753916 |
| 121 | Specific learning disability (HP:0001328) | 1.43151293 |
| 122 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.41296080 |
| 123 | Severe Myopia (HP:0011003) | 1.37219100 |
| 124 | Cystic liver disease (HP:0006706) | 1.35053963 |
| 125 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.31953419 |
| 126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.30389278 |
| 127 | Supranuclear gaze palsy (HP:0000605) | 1.29670977 |
| 128 | Astigmatism (HP:0000483) | 1.26576296 |
| 129 | Genetic anticipation (HP:0003743) | 1.25559682 |
| 130 | Postural instability (HP:0002172) | 1.25108188 |
| 131 | Chorioretinal coloboma (HP:0000567) | 1.22721122 |
| 132 | Pancreatic cysts (HP:0001737) | 1.22476021 |
| 133 | Depression (HP:0000716) | 1.21797198 |
| 134 | Anophthalmia (HP:0000528) | 1.19936992 |
| 135 | Abdominal situs inversus (HP:0003363) | 1.19404812 |
| 136 | Abnormality of abdominal situs (HP:0011620) | 1.19404812 |
| 137 | Interstitial pulmonary disease (HP:0006530) | 1.18298404 |
| 138 | Truncal ataxia (HP:0002078) | 1.16978697 |
| 139 | Focal seizures (HP:0007359) | 1.13714989 |
| 140 | Ependymoma (HP:0002888) | 1.13627894 |
| 141 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.12123049 |
| 142 | Abnormality of the fovea (HP:0000493) | 1.11520612 |
| 143 | Action tremor (HP:0002345) | 1.11485809 |
| 144 | Myokymia (HP:0002411) | 1.11122080 |
| 145 | Hypoplasia of the fovea (HP:0007750) | 1.08166173 |
| 146 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.08166173 |
| 147 | Molar tooth sign on MRI (HP:0002419) | 1.08156501 |
| 148 | Abnormality of midbrain morphology (HP:0002418) | 1.08156501 |
| 149 | Abnormality of the astrocytes (HP:0100707) | 1.06123679 |
| 150 | Astrocytoma (HP:0009592) | 1.06123679 |
| 151 | Insomnia (HP:0100785) | 1.03562730 |
| 152 | Decreased testicular size (HP:0008734) | 1.03157954 |
| 153 | Broad foot (HP:0001769) | 1.02970937 |
| 154 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.02009925 |
| 155 | Ankle clonus (HP:0011448) | 1.01799644 |
| 156 | Intention tremor (HP:0002080) | 0.99259747 |
| 157 | Neoplasm of the oral cavity (HP:0100649) | 0.98586319 |
| 158 | Hemiparesis (HP:0001269) | 0.97951238 |
| 159 | Left ventricular hypertrophy (HP:0001712) | 0.97883089 |
| 160 | Bradykinesia (HP:0002067) | 0.96766264 |
| 161 | Hemiplegia (HP:0002301) | 0.96532733 |
| 162 | Hand muscle atrophy (HP:0009130) | 0.95641862 |
| 163 | Abnormality of binocular vision (HP:0011514) | 0.93657955 |
| 164 | Diplopia (HP:0000651) | 0.93657955 |
| 165 | Asthma (HP:0002099) | 0.93630506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK1 | 7.88362326 |
| 2 | IRAK2 | 3.65729862 |
| 3 | FRK | 3.38299717 |
| 4 | PBK | 3.35891614 |
| 5 | MAP3K9 | 2.89781544 |
| 6 | TAOK3 | 2.76739393 |
| 7 | PINK1 | 2.75299036 |
| 8 | NTRK3 | 2.65791056 |
| 9 | MAP3K4 | 2.55061725 |
| 10 | DAPK2 | 2.51746310 |
| 11 | CASK | 2.22527275 |
| 12 | PAK6 | 2.13029350 |
| 13 | NEK1 | 2.05812961 |
| 14 | STK38 | 2.00549446 |
| 15 | EPHA4 | 1.97158940 |
| 16 | CAMKK2 | 1.91082833 |
| 17 | AKT3 | 1.83800949 |
| 18 | CDK12 | 1.82087058 |
| 19 | PNCK | 1.78503234 |
| 20 | BMPR1B | 1.77358801 |
| 21 | MARK1 | 1.63215932 |
| 22 | ADRBK2 | 1.55946300 |
| 23 | BRD4 | 1.54821385 |
| 24 | WNK4 | 1.47038868 |
| 25 | INSRR | 1.44416920 |
| 26 | MAP4K1 | 1.40344080 |
| 27 | FGFR2 | 1.39522589 |
| 28 | ICK | 1.39247275 |
| 29 | SGK494 | 1.39050084 |
| 30 | SGK223 | 1.39050084 |
| 31 | TYRO3 | 1.38187495 |
| 32 | SIK2 | 1.37373244 |
| 33 | MAP3K10 | 1.35776670 |
| 34 | TXK | 1.29929353 |
| 35 | ALK | 1.29038394 |
| 36 | RIPK4 | 1.27024948 |
| 37 | NTRK2 | 1.26856551 |
| 38 | BLK | 1.21585246 |
| 39 | PRKD3 | 1.20608398 |
| 40 | DYRK1A | 1.19857715 |
| 41 | MINK1 | 1.18680676 |
| 42 | OXSR1 | 1.12685269 |
| 43 | GRK5 | 1.12569968 |
| 44 | GRK6 | 1.12549193 |
| 45 | CAMK1G | 1.12548422 |
| 46 | MAP2K7 | 1.08309003 |
| 47 | PLK2 | 1.03975494 |
| 48 | MAP2K4 | 1.03920047 |
| 49 | PRPF4B | 0.99571993 |
| 50 | CSNK1D | 0.97351902 |
| 51 | MAP2K6 | 0.96872942 |
| 52 | WNK1 | 0.96299935 |
| 53 | BMPR2 | 0.94264839 |
| 54 | HIPK2 | 0.92183424 |
| 55 | SYK | 0.88813637 |
| 56 | ADRBK1 | 0.87962490 |
| 57 | FES | 0.84246791 |
| 58 | ERBB2 | 0.83487930 |
| 59 | PTK2B | 0.83077310 |
| 60 | CAMK1D | 0.82879142 |
| 61 | PRKCH | 0.82873746 |
| 62 | TLK1 | 0.82865307 |
| 63 | TNK2 | 0.82799569 |
| 64 | MAPK10 | 0.82581832 |
| 65 | TTK | 0.81411301 |
| 66 | SGK2 | 0.80499393 |
| 67 | MAPK7 | 0.80240339 |
| 68 | NEK6 | 0.79844679 |
| 69 | TNIK | 0.79374777 |
| 70 | PHKG2 | 0.78366561 |
| 71 | PHKG1 | 0.78366561 |
| 72 | CDC42BPA | 0.78044746 |
| 73 | SGK3 | 0.77561274 |
| 74 | PKN1 | 0.77520779 |
| 75 | MAPK12 | 0.77466682 |
| 76 | MAP4K2 | 0.77233246 |
| 77 | PLK3 | 0.75179558 |
| 78 | TAOK2 | 0.74582865 |
| 79 | LATS2 | 0.74119642 |
| 80 | GSK3B | 0.73744207 |
| 81 | MUSK | 0.73606523 |
| 82 | PRKAA1 | 0.71841373 |
| 83 | CDK3 | 0.71795923 |
| 84 | DYRK2 | 0.71722727 |
| 85 | NUAK1 | 0.70885047 |
| 86 | ITK | 0.70706893 |
| 87 | CDK5 | 0.70665122 |
| 88 | RPS6KA3 | 0.68754452 |
| 89 | PDK1 | 0.66832912 |
| 90 | PRKCB | 0.66733887 |
| 91 | STK11 | 0.65256790 |
| 92 | MAPK9 | 0.65151873 |
| 93 | CAMK2D | 0.63992635 |
| 94 | SGK1 | 0.62973872 |
| 95 | CDK1 | 0.62840542 |
| 96 | PRKD2 | 0.62821453 |
| 97 | MAPK14 | 0.62669172 |
| 98 | MAP3K7 | 0.62602576 |
| 99 | PRKCZ | 0.62352299 |
| 100 | PRKCG | 0.62144019 |
| 101 | CSNK1E | 0.61538175 |
| 102 | CDC7 | 0.60649234 |
| 103 | PRKDC | 0.56896413 |
| 104 | MARK2 | 0.56050318 |
| 105 | CHEK1 | 0.53406496 |
| 106 | OBSCN | 0.53331063 |
| 107 | CAMK2A | 0.52590050 |
| 108 | ATM | 0.52585182 |
| 109 | CAMKK1 | 0.51804203 |
| 110 | CDK2 | 0.50555812 |
| 111 | CAMK1 | 0.49859913 |
| 112 | NEK2 | 0.49605192 |
| 113 | WNK3 | 0.49320492 |
| 114 | STK39 | 0.49203728 |
| 115 | PRKCQ | 0.48843956 |
| 116 | MAPK8 | 0.48789728 |
| 117 | UHMK1 | 0.48388095 |
| 118 | CDK15 | 0.48343193 |
| 119 | DYRK1B | 0.48328808 |
| 120 | PRKACG | 0.47697740 |
| 121 | MTOR | 0.47088981 |
| 122 | CAMK2B | 0.46515304 |
| 123 | CAMK4 | 0.45804890 |
| 124 | CDK9 | 0.44687733 |
| 125 | MAP2K2 | 0.43670226 |
| 126 | AKT2 | 0.43489731 |
| 127 | PRKACA | 0.43377283 |
| 128 | CDK18 | 0.43286395 |
| 129 | BTK | 0.43096648 |
| 130 | CDK19 | 0.42974287 |
| 131 | FER | 0.42666709 |
| 132 | MAPK15 | 0.42433090 |
| 133 | MAP3K11 | 0.42422720 |
| 134 | EPHA2 | 0.42325118 |
| 135 | PIK3CA | 0.41953199 |
| 136 | MAPK13 | 0.41852886 |
| 137 | ATR | 0.41787884 |
| 138 | PAK3 | 0.41474912 |
| 139 | PRKG1 | 0.40616474 |
| 140 | SCYL2 | 0.40484201 |
| 141 | MAP3K13 | 0.40290454 |
| 142 | MAPK1 | 0.39745417 |
| 143 | CDK14 | 0.39424177 |
| 144 | PDPK1 | 0.39154064 |
| 145 | LCK | 0.38715464 |
| 146 | JAK1 | 0.36768063 |
| 147 | EPHB1 | 0.36754525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.71486396 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 2.26942598 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.10607150 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 13.5625061 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 1.82609432 |
| 6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.78722464 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.69930984 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 1.66745431 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.56360206 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.53256178 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.45943569 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.40748815 |
| 13 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.40144827 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.37720386 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31997738 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.30317960 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.23248033 |
| 18 | Circadian rhythm_Homo sapiens_hsa04710 | 1.18930038 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12185220 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.06126340 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.05699428 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01111211 |
| 23 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99499260 |
| 24 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89820535 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88490231 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86604409 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84546048 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83308829 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81480671 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 0.81271120 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81218200 |
| 32 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76705858 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.73757911 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.73676848 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.73352374 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73236251 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73180140 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72923297 |
| 39 | Long-term potentiation_Homo sapiens_hsa04720 | 0.71195189 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71181765 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70857452 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68701763 |
| 43 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68662274 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66976659 |
| 45 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.63620550 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 0.62959372 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62610061 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60134549 |
| 49 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59566186 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59376664 |
| 51 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59192285 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.59186582 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59142848 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58436230 |
| 55 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58163302 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57494870 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56951079 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56528381 |
| 59 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56507812 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55952496 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55829442 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.55719262 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53513119 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53358567 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49343294 |
| 66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49268438 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48777040 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48375123 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.48173399 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46210485 |
| 71 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46035140 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45273313 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44879283 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.44717225 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44418218 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44036478 |
| 77 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43935707 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43268220 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42174928 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41382098 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41348067 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41143205 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41117239 |
| 84 | Alcoholism_Homo sapiens_hsa05034 | 0.40954797 |
| 85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39374502 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38390425 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37744968 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36387739 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.36009854 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35279773 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.35256583 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34776270 |
| 93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34610408 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34333472 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34016506 |
| 96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32834349 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.31184503 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31183965 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30977255 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.30707966 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30341446 |
| 102 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.28868708 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28629067 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28278309 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28040570 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.27739281 |
| 107 | Tight junction_Homo sapiens_hsa04530 | 0.27665844 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.26995734 |
| 109 | RNA degradation_Homo sapiens_hsa03018 | 0.26694679 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.26488805 |
| 111 | Axon guidance_Homo sapiens_hsa04360 | 0.25676732 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.25430090 |
| 113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25102314 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.24638919 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23752499 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23497570 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23365133 |
| 118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.23264845 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22426135 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22143222 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.22013640 |
| 122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.21294180 |
| 123 | Gap junction_Homo sapiens_hsa04540 | 0.21272581 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21081211 |
| 125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.20714911 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.19336621 |
| 127 | Melanogenesis_Homo sapiens_hsa04916 | 0.18705609 |
| 128 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.17350157 |
| 129 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.17239142 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.16376739 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15783971 |

